Cargando…
Pharmacoproteomic characterisation of human colon and rectal cancer
Most molecular cancer therapies act on protein targets but data on the proteome status of patients and cellular models for proteome‐guided pre‐clinical drug sensitivity studies are only beginning to emerge. Here, we profiled the proteomes of 65 colorectal cancer (CRC) cell lines to a depth of > 1...
Autores principales: | Frejno, Martin, Zenezini Chiozzi, Riccardo, Wilhelm, Mathias, Koch, Heiner, Zheng, Runsheng, Klaeger, Susan, Ruprecht, Benjamin, Meng, Chen, Kramer, Karl, Jarzab, Anna, Heinzlmeir, Stephanie, Johnstone, Elaine, Domingo, Enric, Kerr, David, Jesinghaus, Moritz, Slotta‐Huspenina, Julia, Weichert, Wilko, Knapp, Stefan, Feller, Stephan M, Kuster, Bernhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731344/ https://www.ncbi.nlm.nih.gov/pubmed/29101300 http://dx.doi.org/10.15252/msb.20177701 |
Ejemplares similares
-
A microsatellite based multiplex PCR method for the detection of chromosomal instability in gastric cancer
por: Kohlruss, Meike, et al.
Publicado: (2018) -
Precision medicine: from pharmacogenomics to pharmacoproteomics
por: Chambliss, Allison B., et al.
Publicado: (2016) -
Proteome activity landscapes of tumor cell lines determine drug responses
por: Frejno, Martin, et al.
Publicado: (2020) -
Sexual Difference Matters: Females with High Microsatellite Instability Show Increased Survival after Neoadjuvant Chemotherapy in Gastric Cancer
por: Kohlruss, Meike, et al.
Publicado: (2021) -
Significant Tumor Regression after Neoadjuvant Chemotherapy in Gastric Cancer, but Poor Survival of the Patient? Role of MHC Class I Alterations
por: Hiltner, Theresa, et al.
Publicado: (2023)